Drawing for TIGERS

USPTO serial 98765066

TIGERS

Reviewed by CopyMark Law Group

Status 731Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
YOUNG, THOMAS PAUL
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 731: Status 731 means the second six-month extension to file a Statement of Use was granted. File a Statement of Use or the next extension before the deadline expires.

Need help with TIGERS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $249*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Benjamin W. Janke

Benjamin W. Janke Baker, Donelson, Bearman, Caldwell & Berkowitz, A Professional Corporation201 St. Charles Ave., Suite 3600New Orleans, LA 70170United States

Goods and services

ClassDescriptionStatusFirst use
042Platform as a service (PAAS) featuring software to transform, clean, interpret, and group data into episodes used for administering episodes of care; all of the foregoing solely for use in the field of healthcareACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 18, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 17, 2026EX2GSOU EXTENSION 2 GRANTED—
Jul 17, 2026EXT2SOU EXTENSION 2 FILED—
Jul 17, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 30, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 29, 2025EX1GSOU EXTENSION 1 GRANTED—
Oct 29, 2025EXT1SOU EXTENSION 1 FILED—
Oct 29, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2025CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Jul 28, 2025APETASSIGNED TO PETITION STAFF—
Jul 22, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 15, 2025ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jun 3, 2025EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Mar 5, 2025ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Feb 4, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 4, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 29, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 15, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 15, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jan 15, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 15, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 15, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 15, 2025DOCKASSIGNED TO EXAMINER—
Sep 23, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 23, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance